Consumer Driven Health Care

There's a 16.6% increase in the price of drugs in shortage, driven mostly by an increase in the price of generics, according to a new report.

The Federal Trade Commission changed course on previous statements opposing state legislation that would boost transparency over pharmacy benefit managers, as it carries out a sweeping investigation into the industry.

Coverage of Ozempic and Wegovy could conservatively drive employer spend up by 25% annually, so to give the new drugs the best opportunity to have the best effect, employers must think comprehensively and long-term.

Opill's manufacturer, Perrigo, said it wants to make the pill "accessible and affordable" and it's still unclear if it can be covered by insurance, although advocates are pushing for the feds to make no-cost coverage without a prescription a requirement for all over-the-counter contraceptives.

The heat wave running rampant this summer could be responsible for 235,000 ER visits and over 56,000 hospital admissions for heat-related illnesses, a new study estimates.

A Pfizer manufacturing facility in North Carolina, responsible for making 25% of the company's sterile injectable medicines for hospitals, sustained heavy tornado damage, potentially worsening an already deep drug shortage.